Independently of high cholesterol or myocardial damage markers, IL-6 predicts future adverse cardiovascular events and reflects increased inflammatory activity in plaques and is therefore a strong marker of increased risk for mortality in coronary artery diseases [28], [29]. Here, IL6 is linked to coronary artery disorder.